The spondyloarthritides (SpA) are a group of idiopathic inflammatory diseases affecting the
axial and/or peripheral skeleton. Recent evidence points towards an increased mortality and …

Objective. To examine the influence of rheumatoid arthritis (RA) characteristics and
antirheumatic medications on the risk of heart failure (HF) in patients with RA. Methods. A …

Rheumatoid arthritis (RA) is associated with increased cardiovascular (CV) morbidity and
mortality which cannot be fully explained by traditional CV risk factors; cumulative …

Objectives This paper aims to address the concerns around ongoing immune activation,
inflammation, and resistance in those ageing with HIV that represent current challenges for …

Objective Tofacitinib is an oral JAK inhibitor for the treatment of rheumatoid arthritis (RA).
This study was undertaken to evaluate the risk of major adverse cardiovascular events …

Rheumatoid arthritis (RA) associates with excess cardiovascular morbidity and mortality,
resulting in significantly shortened lifespan. Traditional risk factors (eg dyslipidaemia and …

Evidence for the increased risk of cardiovascular morbidity and mortality in patients with
chronic inflammatory and systemic autoimmune diseases has accumulated during the past …

In almost 4 decades since the start of the HIV epidemic, the world has witnessed an
unprecedented evolution of this disease from a debilitating and rapidly fatal syndrome to a …

The identification of modifiable risk factors for the development of rheumatic conditions and
their sequelae is crucial for reducing the substantial worldwide burden of these diseases …

The increased risk of cardiovascular disease (CVD) in rheumatoid arthritis (RA) has been
recognized for many years. However, although the characteristics of CVD and its burden …